PLAY PODCASTS
State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC
Episode 171

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC, explain how Mayo Clinic Laboratories renal genetics testing provides comprehensive, accurate and actionable results. Identifying a genetic cause helps guide the complex decisions involved with t

Answers from the Lab

August 30, 202211m 33s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

(00:31)
 Would each of you share a little about yourselves and your backgrounds?

(01:17)
 Could you please provide us with an overview of what types of genetic testing for inherited kidney diseases are available Mayo Clinic Labs?

(02:35) 
 Can you expand on why genetic testing for kidney disease is important?

(04:30)
 Who could benefit from genetic testing for inherited kidney diseases?

(05:55)
 What types of variants are detected by these new genetic panels at Mayo Clinic Labs?

(07:05)
 How would you say our test matches up to other tests that are currently available?

(08:07)
 What other unique features set the Mayo test apart from some of the competitor offerings?

(09:08)
 Could you summarize the benefits of doing genetic testing for kidney diseases at Mayo Clinic?

(10:01)
 How can a healthcare provider order one of these new inherited kidney disease genetic test panels, and what types of specimens do we accept?

Topics

Full show notes